Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020316

Expand all

OXILAN-300 (IOXILAN)
62%
Marketing Status: Discontinued

Active Ingredient: IOXILAN
Proprietary Name: OXILAN-300
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 62%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020316
Product Number: 001
Approval Date: Dec 21, 1995
Applicant Holder Full Name: GUERBET LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

OXILAN-350 (IOXILAN)
73%
Marketing Status: Discontinued

Active Ingredient: IOXILAN
Proprietary Name: OXILAN-350
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 73%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020316
Product Number: 002
Approval Date: Dec 21, 1995
Applicant Holder Full Name: GUERBET LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information